# Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus

> **NCT00495885** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 848 (actual)

## Conditions studied

- Sleep Initiation and Maintenance Disorders

## Interventions

- **DRUG:** volinanserin (M100907)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00495885
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 848 (ACTUAL)
- **Last updated:** 2016-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00495885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00495885, "Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00495885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*